DK120389B - Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf.

Info

Publication number
DK120389B
DK120389B DK479567AA DK479567A DK120389B DK 120389 B DK120389 B DK 120389B DK 479567A A DK479567A A DK 479567AA DK 479567 A DK479567 A DK 479567A DK 120389 B DK120389 B DK 120389B
Authority
DK
Denmark
Prior art keywords
cycloalkylaminooxazolines
preparation
acid addition
addition salts
salts
Prior art date
Application number
DK479567AA
Other languages
Danish (da)
English (en)
Inventor
R Hiltmann
W Puls
H Wollweber
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK120389B publication Critical patent/DK120389B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK479567AA 1966-09-27 1967-09-26 Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf. DK120389B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0050296 1966-09-27

Publications (1)

Publication Number Publication Date
DK120389B true DK120389B (da) 1971-05-24

Family

ID=7103685

Family Applications (1)

Application Number Title Priority Date Filing Date
DK479567AA DK120389B (da) 1966-09-27 1967-09-26 Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf.

Country Status (12)

Country Link
US (1) US3598833A (es)
AT (2) AT272343B (es)
BE (1) BE704394A (es)
CH (2) CH487917A (es)
DE (1) DE1670753A1 (es)
DK (1) DK120389B (es)
ES (2) ES345506A1 (es)
FR (2) FR1543533A (es)
GB (1) GB1147720A (es)
IL (1) IL28647A (es)
NL (1) NL6713158A (es)
SE (1) SE313055B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102890A (en) * 1972-12-28 1978-07-25 Science-Union Et Cie, Societe Francaise De Recherche Medicale 2-Amino oxazolines and process for making the same
GB1453703A (en) * 1972-12-28 1976-10-27 Science Union & Cie Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4256755A (en) * 1980-04-28 1981-03-17 E. I. Du Pont De Nemours & Company Method of using N-substituted dihydro-2-oxazolamines as analgesics
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5034406A (en) * 1989-09-26 1991-07-23 Allergan, Inc. Method for reducing or maintaining intraocular pressure
US5252595A (en) * 1990-02-28 1993-10-12 Allergan, Inc. Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
US5151440A (en) * 1990-02-28 1992-09-29 Allergan, Inc. Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
US5066664A (en) * 1990-02-28 1991-11-19 Allergan, Inc. 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
US5580892A (en) * 1993-10-22 1996-12-03 Allergan Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
ES2168373T3 (es) * 1994-07-11 2002-06-16 Allergan Sales Inc Derivados biciclicos con conformacion rigida y de adamantano utiles como agentes bloqueadores alfa-2-adrenergicos.
US6150389A (en) * 1994-07-11 2000-11-21 Allergan Sales, Inc. Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution

Also Published As

Publication number Publication date
US3598833A (en) 1971-08-10
SE313055B (es) 1969-08-04
GB1147720A (en) 1969-04-02
FR1543533A (fr) 1968-10-25
NL6713158A (es) 1968-03-28
BE704394A (es) 1968-03-27
ES345506A1 (es) 1968-11-16
IL28647A (en) 1972-02-29
CH487916A (de) 1970-03-31
FR7818M (es) 1970-05-20
AT272343B (de) 1969-07-10
DE1670753A1 (de) 1970-07-16
CH487917A (de) 1970-03-31
ES349034A1 (es) 1969-04-01
AT277239B (de) 1969-12-10

Similar Documents

Publication Publication Date Title
DK125417B (da) Analogifremgangsmåde til fremstilling af amino-dihalogenphenylethylaminer eller syreadditionssalte deraf.
DK120750B (da) Analogifremgangsmåde til fremstilling af azaspiroalkandion-forbindelser eller syreadditionssalte deraf.
DK114981B (da) Fremgangsmåde til fremstilling af basisk substituerede phthalaner eller iso-chromaner eller syreadditionssalte deraf.
DK123022B (da) Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf.
DK120389B (da) Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf.
DK132411B (da) Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf.
DK107288C (da) Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf.
DK114618B (da) Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf.
DK118607B (da) Analogifremgangsmåde til fremstilling af 2-phenylhydrazino-imidazolin-2-forbindelser eller syreadditionssalte deraf.
DK117427B (da) Fremgangsmåde til fremstilling af phenoxypropanolaminer eller syreadditionssalte deraf.
DK115849B (da) Fremgangsmåde til fremstilling af substituerede 2-anilinomethyl-imidazoliner eller syreaddtitionssalte heraf.
DK120345B (da) Fremgangsmåde til fremstilling af halogensubstituerede tetrahydrochinazoliner eller syreadditionssalte deraf.
DK120762B (da) Analogifremgangsmåde til fremstilling af aminoalkyl-substituerede phthalaner eller syreadditionssalte deraf.
DK127066B (da) Analogifremgangsmåde til fremstilling af 5-[phenyldehydropiperidinyl-eller phenyldehydropyrrolidinyl-ethyl]-2-oxazolidinoner eller syreadditionssalte deraf.
DK116662B (da) Fremgangsmåde til fremstilling af pyrazinamider eller syreadditionssalte deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK130587B (da) Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf.
DK119826B (da) Fremgangsmåde til fremstilling af α-6-deoxytetracyclin, α-6-deoxy-5-oxytetracyclin eller syreadditionssalte deraf.
DK115840B (da) Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.
DK121603B (da) Analogifremgangsmåde til fremstilling af arylcarbinoler eller syreadditionssalte deraf.
DK121171B (da) Fremgangsmåde til fremstilling af benzensulfonyl-2-amino-Δ-2-tiazolin eller -3-amino-2-iminotiazolidin eller syreadditionssalte deraf.
DK115696B (da) Fremgangsmåde til fremstilling af 1-cycloalkylidenethyl-4-phenyl-piperidin eller syreadditionssalte heraf.
DK121237B (da) Fremgangsmåde til fremstilling af (alkylaminoætoksy)-dihalogenaniliner eller syreadditionssalte deraf.
DK126376B (da) Analogifremgangsmåde til fremstilling af amidiner eller syreadditionssalte deraf.